Be fit or be sick: Peroxisome proliferator-activated receptors are down the road

被引:175
作者
Desvergne, B [1 ]
Michalik, L [1 ]
Wahli, W [1 ]
机构
[1] Univ Lausanne, Ctr Integrat Genom, Natl Ctr Competence Res Frontiers Genet, CH-1015 Lausanne, Switzerland
关键词
D O I
10.1210/me.2004-0088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Investigating metabolism by unveiling the functions of the nuclear receptors peroxisome proliferator-activated receptors (PPARs) in the numerous intricate pathways ensuring energy homeostasis and fitness has been extremely rewarding. Major lines of research were initially determined by the first-characterized crucial roles of PPARalpha in fatty oxidation and of PPARgamma in adipocyte differentiation and lipid storage. Today, the molecular bases of the functional links between glucose, lipid, and protein metabolism, under the important but nonexclusive control of PPARalpha and PPARgamma, are starting to be uncovered. In addition, in the last couple of years evidence has been provided for an important role of PPARbeta (delta) in lipid metabolism. Inevitably, such actors of metabolic homeostasis are implicated in the physiopathology of complex metabolic disorders, such as those constituting the metabolic syndrome, resulting in atherosclerosis and cardiovascular diseases. This review presents a summary of the recent findings on their dual involvement in health and disease.
引用
收藏
页码:1321 / 1332
页数:12
相关论文
共 103 条
[11]   Troglitazone action is independent of adipose tissue [J].
Burant, CF ;
Sreenan, S ;
Hirano, KI ;
Tai, TAC ;
Lohmiller, J ;
Lukens, J ;
Davidson, NO ;
Ross, S ;
Graves, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2900-2908
[12]   PPARγ is a very low-density lipoprotein sensor in macrophages [J].
Chawla, A ;
Lee, CH ;
Barak, Y ;
He, WM ;
Rosenfeld, J ;
Liao, D ;
Han, J ;
Kang, H ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :1268-1273
[13]   A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis [J].
Chawla, A ;
Boisvert, WA ;
Lee, CH ;
Laffitte, BA ;
Barak, Y ;
Joseph, SB ;
Liao, D ;
Nagy, L ;
Edwards, PA ;
Curtiss, LK ;
Evans, RM ;
Tontonoz, P .
MOLECULAR CELL, 2001, 7 (01) :161-171
[14]  
Chen SY, 2001, SPECTROSC SPECT ANAL, V21, P377
[15]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[16]   Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor [J].
Claudel, T ;
Leibowitz, MD ;
Fiévet, C ;
Tailleux, A ;
Wagner, B ;
Repa, JJ ;
Torpier, G ;
Lobaccaro, JM ;
Paterniti, JR ;
Mangelsdorf, DJ ;
Heyman, RA ;
Auwerx, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2610-2615
[17]   Peroxisome proliferator-activated receptor-γ:: too much of a good thing causes harm [J].
Cock, TA ;
Houten, SM ;
Auwerx, J .
EMBO REPORTS, 2004, 5 (02) :142-147
[18]   Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice [J].
Collins, AR ;
Meehan, WP ;
Kintscher, U ;
Jackson, S ;
Wakino, S ;
Noh, G ;
Palinski, W ;
Hsueh, WA ;
Law, RE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :365-371
[19]   Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-γ ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation [J].
de Dios, ST ;
Bruemmer, D ;
Dilley, RJ ;
Ivey, ME ;
Jennings, GLR ;
Law, RE ;
Little, PJ .
CIRCULATION, 2003, 107 (20) :2548-2550
[20]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688